U-Chart Analysis:JCR Pharmaceuticals Co.,Ltd.:4552

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index JCR Pharmaceuticals Co.,Ltd. Go to web site 4552 Medicals 東証プライム March 1, 2000 1992.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

JCR Pharmaceuticals Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2021年3月期 JCR Pharmaceuticals Co.,Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 18,756 13,278 30,733 26,260 10,973
Other Current AssetsHelp 38,825 34,524 31,455 22,285 17,369
Tangible Fixed AssetsHelp 30,040 32,681 26,782 17,172 14,875
Intangible Fixed AssetHelp 3,496 3,652 2,960 3,232 263
Investments and OthersHelp 11,109 10,802 5,204 4,835 4,295
Total AssetsHelp 102,226 94,937 97,134 73,784 47,775
Total Current LiabilitiesHelp 31,698 37,275 43,300 30,151 11,554
Total Long-term LiabilitiesHelp 14,350 5,500 2,950 5,250 3,831
Shareholder's EquityHelp 56,178 52,162 50,884 38,383 32,390
Total LiabilitiesHelp 102,226 94,937 97,134 73,784 47,775

JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2021年3月期 JCR Pharmaceuticals Co.,Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 42,871 34,343 51,082 30,085 24,781
Total Sales 42,871 34,343 51,082 30,085 24,781
Cost of SalesHelp 11,620 8,886 10,461 7,812 7,901
Other Costs and RevenueHelp 25,742 21,684 26,113 15,380 14,201
Total CostsHelp 37,362 30,570 36,574 23,192 22,102
Net RevenueHelp 31,251 25,457 40,621 22,273 16,880
Earnings Before TaxHelp 7,244 5,412 19,404 8,653 3,422
Net IncomeHelp 5,509 3,773 14,508 6,893 2,679
Net Income 5,509 3,773 14,508 6,893 2,679

JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2024年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2023年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2022年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2021年3月期 JCR Pharmaceuticals Co.,Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 9,312 -5,499 9,289 10,340 4,929
Investing Cash Flow(ICF)Help -2,690 -15,002 -3,250 -3,290 -4,161
Financing Cash FlowHelp -2,031 1,948 -2,179 8,304 2,048
Exchange Difference of Cash and Cash EquivalentsHelp 886 1,099 612 -22 20
Net Increase and Decrease in Cash and Cash Equivalentsn 5,477 -17,454 4,472 15,332 2,836

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

JCR Pharmaceuticals Co.,Ltd.

Company where related level is highHelp

DENKA SEIKEN Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd.
ASKA Pharmaceutical Co.,Ltd.
K Pharma,Inc.
RaQualia Pharma Inc.
StemRIM Inc.
OncoTherapy Science,Inc.
Modalis Therapeutics Corporation
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Tsubota Laboratory Incorporated